Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck Paid $208 Million to Stop Its Drugs From Working
Merck Paid $208 Million to Stop Its Drugs From Working
Merck Paid $208 Million to Stop Its Drugs From Working
Submitted by
admin
on April 14, 2024 - 1:27pm
Source:
Motley Fool
News Tags:
Merck
M&A
Abceutics
antibody-drug conjugate
Headline:
Merck Paid $208 Million to Stop Its Drugs From Working
snippet:
Merck recently acquired a small biotech.
That biotech is making a technology to shut down certain cancer drugs before they harm patients.
It could lead to doctors prescribing some of Merck's medicines more.
Do Not Allow Advertisers to Use My Personal information
